Format

Send to:

Choose Destination
See comment in PubMed Commons below
Indian J Dermatol Venereol Leprol. 2003 May-Jun;69(3):209-11.

Diltiazem vs. nifedipine in chilblains: a clinical trial.

Author information

  • 1Department of Dermatology, STD &Leprosy, Military Hospital, Agra, India, India.

Abstract

BACKGROUND:

The treatment of chilblains remains unsatisfactory. Nifedipine in higher doses remains the mainstay of treatment.

AIMS:

To compare the efficacy of diltiazem with that of nifedipine, and to determine the efficacy of nifedipine in lower doses, 36 chilblains cases were studied.

MATERIAL AND METHODS:

Group A (12 patients) was treated with diltiazem 60 mg thrice daily, and Group B (24 patients) with 10 mg nifedipine thrice daily till complete relief and then maintained on a sustained release preparation of nifedipine 20 mg twice daily.

RESULTS:

Two patients in Group A showed complete relief in 7 days, and 3 patients in about 21 days, but in 7 cases there was little or no response. In group B, 21 cases showed 80-90% relief by the fourteenth day.

CONCLUSIONS:

We conclude that nifedipine remains the drug of choice in chilblains but can be used in a smaller dosage in the Indian population. Diltiazem is less effective in the conventional dose, which may be optimized.

PMID:
17642888
[PubMed]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Medknow Publications and Media Pvt Ltd
    Loading ...
    Write to the Help Desk